CD1a, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD1a, Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD1a, Human |
| Clone | REA736 |
| Host Species | Recombinant Human |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | PE-Vio 770 conjugate |
| Size | 100 tests in 200 µL |
| Concentration | 1:50 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD1a Antibody, anti-human, PE-Vio® 770, REAfinity™. Clone REA736 recognizes the human CD1a antigen, a 40 kDa type I membrane glycoprotein, also known as T6 or Leu-6, which is a member of the immunglobulin superfamily. It shares functional and structural similarities with MHC I class molecules and is associated with β2-microglobulin. CD1a plays a role in antigen presentation by binding lipid and glycolipid antigens and presenting them to T cell receptors on natural killer T cells. CD1a is expressed on Langerhans cells, dendritic cells, and cortical thymocytes. | Additional information: Clone REA736 displays negligible binding to Fc receptors |
| Immunogen | n/a |
| Other Names | HTA1, CD1, FCB6, R4, T6, Leu-6 |
| Gene, Accession # | Gene ID: 909 |
| Catalog # | 130-111-872 |
| Price | $350 |
| Order / More Info | CD1a, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Hanau, D. et al. (1990) Possible mechanism of action of CD1a antigens. J. Invest. Dermatol. 95 (5): 503-505. | Calabi, F. et al. (1991) The CD1 system. Tissue Antigens 37 (1): 1-9. | Blumberg, R. S. et al. (1995) Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol. Rev. 147: 5-29. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies